Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lunit.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bako, Fulgent, Pathnet, Strata, Valar.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Edwards Lifesciences.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abpro, Adagene, Antengene, Astrazeneca, Celltrion.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astellas, Innocare, Innovent, Neuexcell, Radiopharm, Sol-Gel, Takeda, .

Biopharmas in Asia-Pacific raising money in public or private financings: Allink Biotherapeutics, Orum Therapeutics, Rezubio, Syremis Therapeutics, Syneron.

New hires and promotions in the med-tech industry, including: Polypid.

BioWorld Asia briefs for Dec. 23, 2025

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Beren, Grifols, GSK, Johnson & Johnson, Mandos, Spero, Tolmar.